SPINS
SPINSights Hub
Webinars

Overkill or Overdue? Analyzing the new FTC Health Products Compliance Guidelines

Watch Now

Join SPINS Market Insights Director Scott Dicker, food and dietary supplement FDA regulatory attorney Martin Hahn, The Clean Label Project founder Jackie Bowen, and Radicle Science co-founders Dr. Jeff Chen and Pelin Thorogood as we explore the new FTC guidelines and what they could mean for the future of the supplement industry.

KEY LEARNING OBJECTIVES INCLUDE:

  • Understand the role of FTC vs. FDA related to claims enforcement and the possible consequences of making impermissible claims.
  • Learn the key changes and clarifications in the Health Products Compliance Guide vs. the FTC’s 1998 publication.
  • Get valuable tips on how to evaluate your current claims and their level of risk.
  • Learn what type of clinical trials may be required for permissible claims, the investment needed, and the possible ROI from claims.
  • Why these updated guidelines might be good for the industry and your business.
Pelin Thorogood
Radicle Science
M. Eng, MBA - Co-founder, Executive Chairwoman
Jeff Chen
Radicle Science
MD, MBA - Co-founder, Chief Executive Officer
Jaclyn Bowen
Clean Label Project
MPH, MS - Executive Director
Martin Hahn
Hogan Lovells
JD - Partner
Scott Dicker
SPINS
Senior Market Insights Analyst

Ready to use insights to your advantage? We'd love to help you get started.

Chat with Us

About This Webinar:

There has been long-standing uncertainty regarding permissible structure/function claims for supplements. The 1998 Federal Trade Commission (FTC) publication “Dietary Supplements: An Advertising Guide for Industry” has been one of the few government publications on this topic, but it leaves much unstated. For the first time in nearly a quarter century, the FTC updated its guidance with the Health Product Compliance Guide released in December 2022, loaded with 50+ examples of permissible vs. impermissible claims. Some say this signals a forthcoming wave of FTC crackdowns, others say that fear is overblown. Everyone agrees that the quality of data needed for claims, and the risks from making claims, will be higher going forward.

WEBINAR DECK

Overkill or Overdue? Analyzing the new FTC Health Products Compliance Guidelines

Download

Join SPINS Market Insights Director Scott Dicker, food and dietary supplement FDA regulatory attorney Martin Hahn, The Clean Label Project founder Jackie Bowen, and Radicle Science co-founders Dr. Jeff Chen and Pelin Thorogood as we explore the new FTC guidelines and what they could mean for the future of the supplement industry.

KEY LEARNING OBJECTIVES INCLUDE:

  • Understand the role of FTC vs. FDA related to claims enforcement and the possible consequences of making impermissible claims.
  • Learn the key changes and clarifications in the Health Products Compliance Guide vs. the FTC’s 1998 publication.
  • Get valuable tips on how to evaluate your current claims and their level of risk.
  • Learn what type of clinical trials may be required for permissible claims, the investment needed, and the possible ROI from claims.
  • Why these updated guidelines might be good for the industry and your business.
Pelin Thorogood
Radicle Science
M. Eng, MBA - Co-founder, Executive Chairwoman
Jeff Chen
Radicle Science
MD, MBA - Co-founder, Chief Executive Officer
Jaclyn Bowen
Clean Label Project
MPH, MS - Executive Director
Martin Hahn
Hogan Lovells
JD - Partner
Scott Dicker
SPINS
Senior Market Insights Analyst

Registration

To view the webinar, please fill out the following form.

By submitting this form, you agree to SPINS user privacy statement.

Watch Now